Comments
yourfanat wrote: I am using another tool for Oracle developers - dbForge Studio for Oracle. This IDE has lots of usefull features, among them: oracle designer, code competion and formatter, query builder, debugger, profiler, erxport/import, reports and many others. The latest version supports Oracle 12C. More information here.
Cloud Expo on Google News

2008 West
DIAMOND SPONSOR:
Data Direct
SOA, WOA and Cloud Computing: The New Frontier for Data Services
PLATINUM SPONSORS:
Red Hat
The Opening of Virtualization
GOLD SPONSORS:
Appsense
User Environment Management – The Third Layer of the Desktop
Cordys
Cloud Computing for Business Agility
EMC
CMIS: A Multi-Vendor Proposal for a Service-Based Content Management Interoperability Standard
Freedom OSS
Practical SOA” Max Yankelevich
Intel
Architecting an Enterprise Service Router (ESR) – A Cost-Effective Way to Scale SOA Across the Enterprise
Sensedia
Return on Assests: Bringing Visibility to your SOA Strategy
Symantec
Managing Hybrid Endpoint Environments
VMWare
Game-Changing Technology for Enterprise Clouds and Applications
Click For 2008 West
Event Webcasts

2008 West
PLATINUM SPONSORS:
Appcelerator
Get ‘Rich’ Quick: Rapid Prototyping for RIA with ZERO Server Code
Keynote Systems
Designing for and Managing Performance in the New Frontier of Rich Internet Applications
GOLD SPONSORS:
ICEsoft
How Can AJAX Improve Homeland Security?
Isomorphic
Beyond Widgets: What a RIA Platform Should Offer
Oracle
REAs: Rich Enterprise Applications
Click For 2008 Event Webcasts
SYS-CON.TV
Top Links You Must Click On


Tenaxis Medical, Inc. Adds William E. Cohn, MD to Board of Directors
NOVEMBER 29, 2012 - TENAXIS MEDICAL, INC. ANNOUNCED TODAY THE ADDITION OF DR. WILLIAM E. COHN TO ITS BOARD OF DIRECTORS.

MOUNTAIN VIEW, Calif., Nov. 29, 2012 /PRNewswire/ -- Tenaxis Medical, Inc. (www.tenaxismedical.com) a medical device company focused on the development of functionally designed surgical sealants announced today that Dr. William E. Cohn has been added to its board of directors.  Dr. Cohn is a cardiovascular surgeon and the Director of Minimally Invasive Surgical Technology at the Texas Heart Institute in Houston, Texas.  In addition, he is co-director of the Cullen Cardiovascular Research Laboratory, Associate Professor of Surgery at Baylor College of Medicine and Adjunct Professor of Bioengineering at the University of Houston.

A well-respected cardiovascular surgeon, Dr. Cohn is also a prolific inventor and innovator of medical devices that improve patient outcomes.  He has focused on new techniques that involve minimally invasive surgery that allow the surgeon to operate on the beating heart.  These procedures and devices minimize the risk to the patient.

"The board and I are very pleased that Dr. Cohn has agreed to join us as a board member," said Ronald Dieck, President and CEO of Tenaxis Medical, Inc.  "He is an innovative and well respected surgeon who will bring strong medical based guidance to the company.  In addition, Dr. Cohn brings a unique combination of operational, technical, regulatory and financial experience.  He is truly an entrepreneur in his own right."

About Tenaxis Medical, Inc.

Located in Mountain View, CA, Tenaxis Medical, Inc. is a privately held company that began operations in 2006.  It develops novel, high performance sealants that are designed to meet unmet needs throughout various medical procedures.  The products are based on a patent foundation that allows for the development of sealants with wide mechanical and chemical properties.

The company's first product, ArterX® Surgical Sealant, is designed for use in the circulatory system specifically for controlling bleeding at the attachment sites of two blood vessels or the connection of a synthetic vascular graft to a blood vessel.  The results of its pivotal clinical study have recently been published in the Annals of Vascular Surgery.  ArterX Surgical Sealant has its CE Mark and is sold throughout most of Europe.  A Premarket Approval Application (PMA) has been submitted to the FDA and is currently under evaluation. 

The company is developing a second high performance sealant for use throughout the gastrointestinal tract.  Prevent™ GI Sealant will be designed to meet the more challenging environment of the GI tract where exposure to acidic conditions and enzymatic degradation are not uncommon.

A third product will be developed for the prevention of surgical adhesions.  This will have the ability to be delivered laparoscopically as a spray that will help to reduce or prevent pelvic and abdominal adhesions.  Surgical adhesions are perhaps the largest complication to many common surgical procedures.

Contact: Ronald Dieck, (650) 691-9016, x 110

SOURCE Tenaxis Medical, Inc.

About PR Newswire
Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Enterprise Open Source Magazine Latest Stories . . .
StackIQ offers a comprehensive software suite that automates the deployment, provisioning, and management of Big Infrastructure. With StackIQ’s software, you can spin up fully configured big data clusters, quickly and consistently — from bare-metal up to the applications layer — and ma...

Unless you have been living under a rock the last year, you have probably heard about Docker. Docker describes itself as an open platform for distributed applications for developers and sysadmins. That sounds great, but why does it matter? Wait, virtualization isn’t new!? Virt...

When I took my operating systems fundamentals course in college I was taught that an operating system provides very specific capabilities that provides users with access compute resources for building and running applications. Over time as networking capabilities and bandwidth increase...
There's fog coming to the world of IT. Some people are calling this "The Cloud." This fog turns everything inside out. It will take your monolithic applications, the guts of which are contained within large bodies of code, and break them apart so that discrete units of functionality a...
DevOps is a discontinuous innovation in the way organizations develop and deliver software. And as with any new discontinuous innovation, the implication is that creative destruction will follow. Companies that hold on to legacy business and technology models, without pursuing the ev...
What are the benefits of using an enterprise-grade orchestration platform? In their session at 15th Cloud Expo, Jeff Tegethoff, CEO of Appcore, and Kedar Poduri, Senior Director of Product Management at Citrix Systems, will take a closer look at the architectural design factors neede...
Subscribe to the World's Most Powerful Newsletters
Subscribe to Our Rss Feeds & Get Your SYS-CON News Live!
Click to Add our RSS Feeds to the Service of Your Choice:
Google Reader or Homepage Add to My Yahoo! Subscribe with Bloglines Subscribe in NewsGator Online
myFeedster Add to My AOL Subscribe in Rojo Add 'Hugg' to Newsburst from CNET News.com Kinja Digest View Additional SYS-CON Feeds
Publish Your Article! Please send it to editorial(at)sys-con.com!

Advertise on this site! Contact advertising(at)sys-con.com! 201 802-3021




SYS-CON Featured Whitepapers
ADS BY GOOGLE